Trials / Recruiting
RecruitingNCT03297775
Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 750 (estimated)
- Sponsor
- University of Colorado, Denver · Academic / Other
- Sex
- All
- Age
- 45 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The overall goal of this study is to define the phenotype of Interstitial Lung Disease (ILD), and identify factors that predict radiologic progression in those with subclinical RA-ILD, in patients with rheumatoid arthritis (RA). The investigators hypothesize that there are common core elements (e.g. clinical features, genetic variants, and/or biologic markers) between other forms of ILD (e.g. idiopathic pulmonary fibrosis, IPF) and subclinical RA-ILD that places individuals at risk for the development of lung disease.
Conditions
Timeline
- Start date
- 2017-06-22
- Primary completion
- 2027-06-01
- Completion
- 2027-06-01
- First posted
- 2017-09-29
- Last updated
- 2023-11-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03297775. Inclusion in this directory is not an endorsement.